HealthTree Logo
search more_vert
close
person Sign In / Create Account
Clinical Trial: BOSTON Trial, Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
Posted: May 18, 2018
Clinical Trial: BOSTON Trial, Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma image

The BOSTON trial is a phase 3 study comparing weekly oral selinexor + bortezomib + low-dose dexamethasone (SVd) versus bortezomib (twice weekly) + low-dose dexamethasone (Vd) in patients with relapsed or refractory multiple myeloma.

Patients whose myeloma progresses on the Vd arm may be eligible to “cross over” onto the SVd arm.

Selinexor is the first in a new class of drugs being investigated as a treatment for myeloma. It belongs to a class of drug called selective inhibitor of nuclear export (SINE) and works by disrupting survival mechanisms in myeloma cells. Watch the video below to hear David Siegel, MD, PhD (John Theurer Cancer Center) explain Selinexor as a myeloma therapy.

In order to qualify for this study:

  • Patients must have relapsed or refractory disease
  • Patients must have received between 1-3 prior lines of therapy
  • Patients must not have prior exposure to Selinexor.

This trial is open and accepting patients at over 150 locations throughout the world. Click the link below to learn more about this study and see if you are eligible. You can also call SparkCures with any questions at (888) 828-2206.

To learn more about this clinical trial, click here:

BOSTON Trial

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation. 

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
GSK
Regeneron
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube